Key Takeaways
- • EQT warns that market deterioration will materially impact its exit agenda in 2026, signaling headwinds for private equity realizations despite posting record €34 billion in exits during 2025 across 30+ exit events.
- • Alternative energy assets held by PE portfolios face elevated exit risks as market conditions tighten, constraining the firm's ability to execute planned divestitures in the current environment.
- • EQT maintains limited direct tariff exposure across its portfolio, but broader market deterioration—not tariffs alone—is the primary constraint on exit execution this year.
- • The firm's recent Tubulis exit to Gilead Sciences (valued up to $5 billion) and ongoing share buybacks demonstrate capital recycling strategies, though these cannot offset systemic challenges in exit velocity across the PE industry.
- • EQT CEO Per Franzen has publicly warned that 80% of PE firms could become "zombie funds" by 2035 due to capital concentration and competitive pressures, positioning the world's second-largest PE manager as better positioned than smaller peers to navigate a prolonged exit slowdown.
Summary
EQT, the world's second-largest private equity firm by funds raised, has issued a cautionary assessment regarding its exit strategy for 2026, signaling that market deterioration poses material risks to its realization agenda despite an exceptional 2025 performance. According to statements from the firm and reporting from Bloomberg and the Wall Street Journal, EQT achieved record exits in 2025 with over 30 exit events generating approximately €34 billion in realizations. However, the firm has explicitly warned that this momentum will not carry forward into 2026, as broader market conditions—rather than tariff exposure alone—are constraining exit opportunities.
The specific concern centers on alternative energy assets held within PE portfolios, which face heightened exit risks in the current environment. While EQT has confirmed that its portfolio maintains limited direct exposure to tariffs, the firm acknowledges that systemic market deterioration is dampening buyer appetite and valuations across sectors, particularly in the renewable and alternative energy space. This creates a structural challenge for PE firms seeking to crystallize gains or refinance maturing positions. The firm's comment that "market deterioration will impact EQT's exit agenda this year" signals management's expectation of materially slower realization activity compared to 2025's record performance.
EQT's broader strategic outlook has been shaped by CEO Per Franzen's increasingly public warnings about structural fragmentation within the private equity industry. Franzen has cautioned that approximately 80% of PE firms could become "zombie funds" by 2035 under current market conditions and competitive dynamics, driven by capital concentration among larger players and slower exit velocity. This positions EQT—with €270 billion in assets under management as of December 2025 and €141 billion in fee-generating AUM—as a consolidator capable of acquiring distressed assets from competitors unable to execute exits or fundraising objectives.
Recent capital recycling initiatives underscore EQT's focus on maintaining momentum during the exit slowdown. In early April 2026, EQT Life Sciences agreed to sell its minority stake in clinical-stage biotech company Tubulis to Gilead Sciences for up to $5 billion, marking a significant healthcare realization. Simultaneously, EQT AB initiated share repurchase programs on Nasdaq Stockholm, combining asset sales with capital returns to equity holders. These actions reflect EQT's strategy of preserving fee-earning capacity and supporting shareholder returns even as exit volumes contract industry-wide.
The broader industry context reveals that private equity firms have struggled with weak payouts to investors for four consecutive years, with extended holding periods and delayed exits becoming structural features rather than temporary market anomalies. EQT's warnings align with this deteriorating backdrop, suggesting that the €11 billion in gross fund exits achieved in 2024 (representing a 72% increase over 2023) may represent a cyclical peak rather than a sustained trend. The firm's Q1 2026 report, anticipated for April 22, will provide critical guidance on realization activity, fee income trajectory, and fundraising momentum against a backdrop of tightening exit markets.
The specific concern centers on alternative energy assets held within PE portfolios, which face heightened exit risks in the current environment. While EQT has confirmed that its portfolio maintains limited direct exposure to tariffs, the firm acknowledges that systemic market deterioration is dampening buyer appetite and valuations across sectors, particularly in the renewable and alternative energy space. This creates a structural challenge for PE firms seeking to crystallize gains or refinance maturing positions. The firm's comment that "market deterioration will impact EQT's exit agenda this year" signals management's expectation of materially slower realization activity compared to 2025's record performance.
EQT's broader strategic outlook has been shaped by CEO Per Franzen's increasingly public warnings about structural fragmentation within the private equity industry. Franzen has cautioned that approximately 80% of PE firms could become "zombie funds" by 2035 under current market conditions and competitive dynamics, driven by capital concentration among larger players and slower exit velocity. This positions EQT—with €270 billion in assets under management as of December 2025 and €141 billion in fee-generating AUM—as a consolidator capable of acquiring distressed assets from competitors unable to execute exits or fundraising objectives.
Recent capital recycling initiatives underscore EQT's focus on maintaining momentum during the exit slowdown. In early April 2026, EQT Life Sciences agreed to sell its minority stake in clinical-stage biotech company Tubulis to Gilead Sciences for up to $5 billion, marking a significant healthcare realization. Simultaneously, EQT AB initiated share repurchase programs on Nasdaq Stockholm, combining asset sales with capital returns to equity holders. These actions reflect EQT's strategy of preserving fee-earning capacity and supporting shareholder returns even as exit volumes contract industry-wide.
The broader industry context reveals that private equity firms have struggled with weak payouts to investors for four consecutive years, with extended holding periods and delayed exits becoming structural features rather than temporary market anomalies. EQT's warnings align with this deteriorating backdrop, suggesting that the €11 billion in gross fund exits achieved in 2024 (representing a 72% increase over 2023) may represent a cyclical peak rather than a sustained trend. The firm's Q1 2026 report, anticipated for April 22, will provide critical guidance on realization activity, fee income trajectory, and fundraising momentum against a backdrop of tightening exit markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.